series-b
Stage
2
Investors
About
Octant develops next-generation small molecule therapeutics using advanced DNA sequencing, gene synthesis, and gene editing to target complex cellular mechanisms underlying genetic diseases such as retinitis pigmentosa.
Explore Octant's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.